⌘K
Loading ticker…
As of 2026-08-24, Dyne Therapeutics, Inc. Common Stock (DYN) has a 3-month relative strength percentile of 94 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 69. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 4.3%, relative volume 0.69×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
DYN is in a stage 2 uptrend, week 1. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 9.6% / 32.4%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
DYN is held by 22 ETFs as of May 2026. Top owner: SCHA at 0.06% weight, $13M notional. Top 3 carry $33M.
Held by 64 ETFs · $399M across latest filings · largest weight 2.36% (IBRN).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| SCHASchwab U.S. Small-Cap ETF | 0.06% | $13M | — |
| VTWO | 0.08% | $13M | +0.01 pp |
| VHTVanguard Health Care ETF | 0.04% | $7M | — |
| SCHBSchwab U.S. Broad Market ETF | 0.00% | $2M | — |
| ESML | 0.06% | $1M | +0.02 pp |
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| VTWV | 0.11% | $1M | +0.02 pp |
| VFMO | 0.05% | $910K | — |
| ONEQ | 0.01% | $851K | — |
| VTWG | 0.05% | $769K | — |
| VTHRVanguard Russell 3000 ETF | 0.00% | $220K | — |
Showing 10 of 22 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | DYN Jan avg: 9.67% median: 8.72% win: 50% σ: 43.41% n: 4 2022-04-12 → 2026-07-31 | DYN Feb avg: -0.77% median: -8.04% win: 25% σ: 18.04% n: 4 2022-04-12 → 2026-07-31 | DYN Mar avg: -3.02% median: -2.51% win: 50% σ: 17.32% n: 4 2022-04-12 → 2026-07-31 | DYN Apr avg: -5.41% median: -10.07% win: 20% σ: 11.06% n: 5 2022-04-12 → 2026-07-31 | DYN May avg: 4.72% median: 10.14% win: 80% σ: 26.97% n: 5 2022-04-12 → 2026-07-31 | DYN Jun avg: 6.87% median: 10.70% win: 60% σ: 25.19% n: 5 2022-04-12 → 2026-07-31 | DYN Jul avg: 19.88% median: 13.37% win: 100% σ: 19.53% n: 5 2022-04-12 → 2026-07-31 | DYN Aug avg: 7.85% median: 0.50% win: 50% σ: 20.48% n: 4 2022-04-12 → 2026-07-31 (current) | DYN Sep avg: -5.03% median: -13.81% win: 25% σ: 24.21% n: 4 2022-04-12 → 2026-07-31 | DYN Oct avg: 6.82% median: -14.95% win: 25% σ: 48.03% n: 4 2022-04-12 → 2026-07-31 | DYN Nov avg: 15.71% median: 4.35% win: 75% σ: 27.89% n: 4 2022-04-12 → 2026-07-31 | DYN Dec avg: -3.65% median: -5.81% win: 25% σ: 18.20% n: 4 2022-04-12 → 2026-07-31 |